疫苗相关性脑膜炎及其相关疫苗的全球负担,1967-2023年
Jiyeon Oh1,2, Seoyoung Park2, Jaeyu Park2,3
1Department of Medicine, Kyung Hee University College of Medicine, Seoul, Korea (the Republic of).
The British journal of ophthalmology
|October 18, 2024
概括
接种疫苗,特别是COVID-19 mRNA疫苗,与罕见的脑膜炎风险有关,特别是在女性中. 持续监测对于监测疫苗安全性和潜在不良事件至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 疫苗学 疫苗学 疫苗学
- 药物监督 药物监督 药物监督
背景情况:
- 尿道炎是接种疫苗后的罕见不良事件.
- 在COVID-19大流行期间,耳膜炎的报告增加了.
- 营销后监测对于疫苗安全至关重要.
研究的目的:
- 评估各种疫苗和脑膜炎之间的关联.
- 为了确定与膜炎风险增加相关的特定疫苗.
- 分析疫苗相关性脑膜炎的人口结构模式.
主要方法:
- 使用药监督病例/非病例研究设计.
- 分析了1967年至2023年的疫苗安全数据.
- 使用不成比例分析来检测安全信号.
主要成果:
- 检测到疫苗和脑膜炎之间存在显著的关联 (ROR, 1.64).
- COVID-19 mRNA 疫苗显示出最强的信号 (ROR, 5.76).
- 其他相关疫苗包括乙型肝炎,乳头瘤病毒,腺病毒5载体COVID-19和流感疫苗,主要用于女性.
结论:
- 接种疫苗,特别是COVID-19 mRNA疫苗,构成患上脑膜炎的罕见风险.
- 这种关联在不同年龄组的女性中更为明显.
- 持续的药物监测对于识别和管理与疫苗相关的不良事件至关重要.
相关概念视频
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Cross-reactivity
31.0K
Overview
31.0K


